Amesite (AMST)
AI documentation and workflow tools for nurses and post-acute care organizations.
Something off on this page? Send us feedback.
Sells hosted AI subscriptions centered on NurseMagic, which converts nursing inputs into structured documentation and workflow support for practitioners and post-acute organizations. Revenue is primarily subscription-based within a single reportable segment, while the legacy learning platform remains without growth investment.
Sells NurseMagic subscription tools to individual care professionals and post-acute organizations, covering documentation, clinical-information assistance, patient communications, and career tools. Organization users can dictate once, generate structured note drafts, fill fields in existing EMRs, check required elements, and route gaps for clinician review. Pricing scales by active clinician, site, or patient census.
Expands this healthcare focus with an AI-native NurseMagic EMR intended to coexist with or replace legacy systems, while LynkMagic is marketed to fiscal intermediaries, senior-living owners, and enterprise workforce uses. The legacy Amesite Engage learning platform still serves its installed base but receives no growth investment. Revenue comes mainly from hosted-solution subscriptions, and adoption depends on security, regulatory alignment, and integration with care workflows.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Mar 31, 2026Cash & short-term investments $640.7K · Total debt $0 · Total assets $1.5M · Shareholders' equity $1.3M
- Revenue
- $83.3K
- Operating income
- −$684.1K
- Net income
- −$678.1K
No dividends on record.
| Insiders | 49.72% | 2.91M shares | |
|---|---|---|---|
| 5 holders · as of May 18, 2026 | |||
| Other | 50.28% | 2.94M shares | |
| remainder | |||
5.85M company shares as of Sep 22, 2026 · holders as of their latest filing
Two share counts disagree (5.85M in the company's Sep 22, 2026 report, 6.55M elsewhere); stakes use the report.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Ann Marie SastryInsiderdirector, officer: CHIEF EXECUTIVE OFFICER | 32.89% | 1.93M | filed May 18, 2026 |
George ParmerInsiderdirector | 9.69% | 566,962 | filed May 18, 2026 |
Gilbert S. OmennInsiderdirector | 2.46% | 143,699 | filed Mar 10, 2026 |
J. Michael LoshInsiderdirector | 2.36% | 138,200 | filed Mar 10, 2026 |
Barbie BrewerInsiderdirector | 2.32% | 135,977 | filed Mar 10, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Apr 28, 2026 | George Parmer | director | +731,706 | $1.44 |
| Apr 28, 2026 | Ann Marie Sastry | director, officer: CHIEF EXECUTIVE OFFICER | +522,648 | $1.44 |
